Risk factors

BioAtla (BCAB) risk factors

Item 1A of every BioAtla, Inc. 10-K on file, and what changed from one year to the next.

Open BCAB in Gloomberb →
  • FY2025 10-K risk factors

    90 risks, 12 new, 4 dropped, 15 reworded since the prior year. The company is exploring strategic options including asset sales, restructuring with a 70% workforce reduction, and facing Nasdaq delisting threats due to minimum bid price deficits.

    Filed Mar 31, 2026
  • FY2024 10-K risk factors

    82 risks. BioAtla relies heavily on its unproven CAB technology platform and needs substantial capital to fund its clinical programs.

    Filed Mar 28, 2025